Replacing vulnerable ingredients with climate resilient alternatives, using upcycled ingredients or byproducts to reduce dependency on single-source crops, investing in lab grown alternatives.
*Lunch to be served in session
- Lessons from moving regenerative practices beyond demonstration projects.
- Financing and policy levers that unlock widespread adoption, including the role of soil carbon credits as a funding mechanism.
- How to accelerate uptake without losing integrity, ensuring outcomes remain high-quality and verifiable.
Moderators
Roberta McDonald
Director of Programme
Agreena
Roberta McDonald is a Sustainable Agriculture Leader with over a decade of experience enhancing sustainability in agriculture. As Director of Program at Agreena in Copenhagen, she leads the science, standards and data quality teams in the development of certified carbon farming solutions. Her background includes roles at Devenish and Aurivo Dairy Co-op in Ireland, focusing on innovative solutions and farmer-led initiatives. With a Nuffield scholarship, PhD in Agricultural Sciences and a strong connection to her dairy farm upbringing, Roberta is dedicated to empowering farmers and advancing sustainable food systems.
Iso Neville
Global Marketing & Communications
Agreena
Iso Neville leads Global Marketing & Communications at Agreena, the European leader in verified soil carbon solutions. Drawing on her cross-sector experience and Master’s in Sustainable Fashion, Iso specialises in developing people-centred communications strategies that inspire real-world action. She is deeply passionate about telling the stories behind scalable solutions that tackle the climate crisis head-on.
Charlie Webb
Senior Solutions Manager
Agreena
Charlie is Senior Solutions Manager at Agreena, the European leader in verified soil carbon solutions, where he focuses on Scope 3 decarbonisation. Drawing on cross-sector experience in sustainable agriculture and partnerships, Charlie specialises in creating scalable regenerative agriculture programmes that drive measurable carbon outcomes across the supply chain. At FutureChain, Charlie will explore how regen ag programmes can be a practical, commercially viable lever for businesses looking to decarbonise their Scope 3 and why verified, nature-based solutions are key to getting there.
Agreena
Website: agreena.com
Headquartered in Denmark, Agreena is powering the global transition to regenerative agriculture, operating Europe’s leading soil carbon programme. Through its flagship AgreenaCarbon project, which is the first large-scale agricultural cropland initiative registered under Verra's world-renowned Verified Carbon Standard, Agreena collaborates with thousands of farmers across 4.5 million hectares of arable land in 20 markets.
Agreena finances farmers’ transition to sustainable practices, measures and verifies the climate impact with field-level accuracy, and offers climate solutions to corporates to achieve their sustainability goals.
Agreena’s holistic solution is built on three pillars: farmer engagement, which provides essential financing, knowledge, and resources to support growers in making impactful change; scalable dMRV, integrating satellite imagery, ground-level soil sampling and proprietary AI models to precisely quantify practice changes and carbon outcomes at scale; and verified carbon and environmental data, empowering companies to make credible sustainability claims, support farmer-led climate action and access high-integrity carbon credits.
- How sanctions, trade restrictions, or export bans impact access to critical ingredients.
- Mapping vulnerabilities in agriculture, natural and synthetic ingredient supply chains.
- Strategies for diversifying sourcing regions and suppliers.
Patrick Grady
CEO
TetraScience
Patrick serves as co-founder, chairman, and CEO of TetraScience. Prior to TetraScience, Patrick spent three decades building, backing, and scaling market-defining companies and technology stacks within the high-performance computing, SaaS, cloud, and AI markets.
Patrick was the founder, CEO, and CTO of the first intelligent agent company of the Internet era, built one of the world’s first three SaaS companies, the first enterprise SaaS business, one of the first ten global technology unicorns, and the first AI unicorn.
To deliver these AI agents to market, Patrick played a well-documented role in pioneering and/or commercializing several enabling technologies, including web services, SOA, and multi-tenancy, which now undergird the trillion-dollar cloud market.
Recognized as a leading innovator by numerous publications and peer groups over the years, Patrick was a recipient of the 2006 Fast Company award, given to the top 50 people in the world most likely to change the way we live and work for his seminal efforts in personal agent AI.
Lydia Gushgari, PhD
Chief of Staff
SPOC Biosciences
Jim Villa
Global Head, Research Strategy & Operations
Takeda
- Developing a mechanistic model of IVT to include nucleation and growth of magnesium pyrophosphate crystals and subsequent agglomeration of crystals and DNA.
Nathan Stover
Engineer
BioCurie
Zhaoqian Su
AI Scientist
Takeda
Melissa Landon
Head, Commercial & Business Development, AI & Automation
MilliporeSigma
Dr. Melissa (“Mel”) Landon leads Commercial and Business Development for AI and Automation at Millipore Sigma, the Life Science business of Merck KGaA. With 20 years of experience of building cutting edge platforms across pharma and tech, Mel’s current work focuses on scaling intelligent automation and AI solutions that bridge scientific innovation with commercial value. She brings to this role a cross-disciplinary background spanning life sciences, technology partnerships, and enterprise transformation. Prior to joining MilliporeSigma, Melissa served as Chief Strategy Officer at Cyclica, an AI-enabled tech bio company (acquired by Recursion in 2023). Melissa completed her PhD in Bioinformatics at Boston University and performed postdoctoral studies in biochemistry and X-ray crystallography at Brandeis University.
Sagar Jain
Director, Digital AI Strategy SSF
Roche